Company Filing History:
Years Active: 2020-2024
Title: Innovations in Cancer Therapy by Sunny Kumar
Introduction
Sunny Kumar is an accomplished inventor based in Aliso Viejo, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative cancer therapies. With a total of 3 patents to his name, Kumar is dedicated to advancing medical treatments that can improve patient outcomes.
Latest Patents
Kumar's latest patents focus on polymer-drug conjugates for combination anticancer therapy. These pharmaceutical compositions comprise two or more therapeutically active agents, such as anticancer agents, conjugated to biocompatible polymers. The unique aspect of these compositions is that the molar ratio of the agents and the schedules of delivery are designed to provide a synergistic therapeutic effect. The patents describe methods of making and using these compositions, which include topoisomerase I and topoisomerase II inhibitors conjugated to the same or different biocompatible polymers. The anticancer agents are covalently coupled to the polymers, allowing for targeted delivery to tumors at a molar ratio that enhances their effectiveness. Additionally, the agents can be coupled indirectly to the polymers via a linker, further optimizing their therapeutic potential.
Career Highlights
Sunny Kumar is affiliated with the University of California, where he conducts research and develops innovative solutions in the pharmaceutical field. His work is characterized by a commitment to improving cancer treatment methodologies through scientific research and innovation.
Collaborations
Kumar collaborates with notable colleagues, including Kathryn M Camacho and Stefano Menegatti. These partnerships enhance the research efforts and contribute to the development of groundbreaking therapies.
Conclusion
Sunny Kumar's contributions to cancer therapy through his innovative patents demonstrate his dedication to improving healthcare outcomes. His work in polymer-drug conjugates represents a significant advancement in the field of pharmaceuticals, showcasing the potential for enhanced treatment strategies in oncology.